Events

5th EMMC International Workshop 2025
APR
Tue
08
APR
Wed
09
APR
Thu
10

Starts in 1 week from now

Location

TU Vienna (main building)

Programmes
Digital, Industry & Space

Accelerating innovation in advanced materials and ensuring sustainability requires a step-change not only in materials research techniques such as advanced modelling and characterisation methods, but also in bringing together expertise and information (data with meaning) that meets the highly complex decisions that underly the innovation process and materials life cycle. Required are much improved, FAIR data integration, trust and transparency, fast, reliable and traceable decision systems, as well as sophisticated models.

The European Materials Modelling Council 2025 International Workshop will discuss advances and future directions in how both accelerated innovation and sustainability are supported by a Knowledge Ecosystem based on materials modelling and data integration.

The workshop will discuss these points from different perspectives including

  • Advancements in modelling and integration with characterisation
  • Digitalisation and Interoperability including Materials Commons [2]
  • Software development, deployment and maintenance
  • Adoption in industrial ecosystems
  • Sustainability
  • Policy

More information and registration are available here. 

Please note that there is a registration fee for this event.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.